Guangzhou, China

Suhua Guan

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Suhua Guan in Immunogenic Composition for SARS-COV-2

Introduction

Suhua Guan is an accomplished inventor based in Guangzhou, China. He has made significant contributions to the field of immunology, particularly in the development of innovative solutions for combating viral infections. His work focuses on creating effective immunogenic compositions that can induce immune responses against SARS-COV-2.

Latest Patents

Suhua Guan holds a patent for an AD35-vectored immunogenic composition aimed at addressing SARS-COV-2 infection. This patent, which is a replication-defective Ad35-vectored immunogenic composition, is designed to induce an immune response against SARS COV-2. The composition includes an Ad35 vector that encodes the optimized nucleic acid sequence of SEQ ID NO: 1. Notably, some embodiments of this disclosure demonstrate improved safety and convenience of use. Experimental results indicate that the immunogenic composition can produce a higher quantity of S proteins in human cells. Furthermore, this composition may be utilized in conjunction with other immunogenic compositions or as a therapeutic option for Corona Virus Disease 2019. When administered at the initial stage of infection, the Ad35-vectored immunogenic composition effectively induces an immune response, achieving a therapeutic effect.

Career Highlights

Suhua Guan is associated with Guangzhou N Biomed Ltd., where he continues to advance his research and development efforts. His innovative work has positioned him as a key figure in the field of biomedicine, particularly in the fight against viral diseases.

Collaborations

Suhua Guan collaborates with notable colleagues, including Ling Chen and Chenchen Yang, who contribute to his research initiatives and projects.

Conclusion

Suhua Guan's innovative contributions to the field of immunology, particularly through his patent for an AD35-vectored immunogenic composition, highlight his commitment to advancing medical science. His work not only addresses current health challenges but also paves the way for future developments in therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…